Here's some timely weekend reading for all you drugwonks out there:
The first is a nice omnibus article from the current edition of Nature Biotechnology, "One year in -- Obama's biotech scorecard."
The next piece is from the Belgian medical publication Le Generaliste. It's focus is on American healthcare reform. It's in French and is headlined, "USA: les soins de sante a la croisee des chemins" (US healthcare at a crossroads).
And finally a new piece in Commentary by our good pal Tevi Troy, "Health Care: A Two-Decade Blunder."
Enjoy.
The first is a nice omnibus article from the current edition of Nature Biotechnology, "One year in -- Obama's biotech scorecard."
The next piece is from the Belgian medical publication Le Generaliste. It's focus is on American healthcare reform. It's in French and is headlined, "USA: les soins de sante a la croisee des chemins" (US healthcare at a crossroads).
And finally a new piece in Commentary by our good pal Tevi Troy, "Health Care: A Two-Decade Blunder."
Enjoy.
